You are here:Home-Chemical Inhibitors & Agonists-Tyrosine Kinase-c-Met (HGFR)-Merestinib
Merestinib

Chemical Structure : Merestinib

CAS No.: 1206799-15-6

Merestinib (LY2801653, LY-2801653)

Catalog No.: PC-20333Not For Human Use, Lab Use Only.

Merestinib (LY2801653) is a potent, selective, type-II ATP competitive inhibitor of c-Met with Ki of 2 nM, inhibits c-MET wt and mutant Y1230C with IC50 of 42 and 54 nM, respectively.

Packing Price Stock Quantity
5 mg $88 In stock
10 mg $128 In stock
25 mg $218 In stock
50 mg $358 In stock
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

Merestinib (LY2801653) is a potent, selective, type-II ATP competitive inhibitor of c-Met with Ki of 2 nM, inhibits c-MET wt and mutant Y1230C with IC50 of 42 and 54 nM, respectively.
LY2801653 inhibited MET auto-phosphorylation in HGF-stimulated H460 cells and S114 cells with IC50 of 35.2 and 59.2 nM, resepctively.
LY2801653 inhibited growth of a panel of MET mutated variant clones with an IC50 ranging from 3-fold more potent (V1092I) to approximately 6-fold less potent (L1195V) compared with the growth inhibition of cells with the MET wild-type sequence.
LY2801653 demonstrated more potent anti-proliferative activity in cell lines with MET gene amplification (MKN45, Hs746T and H1993) than the cell lines without MET gene amplification (U-87MG, KATO-III).
LY2801653 (12 mg/kg, BID, oral) demonstrated in vivo anti-tumor activity in MET-dependent U-87MG and H441 xenograft models.

Physicochemical Properties

M.Wt 552.54
Formula C30H22F2N6O3
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

N-[3-fluoro-4-[[1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5-yl]oxy]phenyl]-1-(4-fluorophenyl)-1,2-dihydro-6-methyl-2-oxo-3-pyridinecarboxamide

References

1. Yan SB, et al. Invest New Drugs. 2013 Aug;31(4):833-44.

2. Wu W, et al. Clin Cancer Res. 2013 Oct 15;19(20):5699-710.

3. Kawada I, et al. Cancer Res. 2014 Feb 1;74(3):884-95.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: